Mckesson (MCK) Net Income towards Common Stockholders (2009 - 2026)
Mckesson (MCK) reported Net Income towards Common Stockholders of $1.9 billion for Q1 2026, up 42.04% year-over-year from $1.3 billion in Q1 2025, and up 48.4% quarter-over-quarter from $1.2 billion in Q4 2025.
Mckesson (MCK) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 17 years of Net Income towards Common Stockholders data on file, last reported at $1.9 billion in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at $1.9 billion, up 42.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 billion (up 46.48% YoY), and the FY2026 annual result was $5.1 billion, changed N/A from the prior year.
- Net Income towards Common Stockholders improved to $1.9 billion in Q1 2026 per MCK's latest filing, from $1.2 billion in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $1.9 billion in Q1 2026 and troughed at -$6.0 million in Q3 2022.
- A 4-year average of $714.6 million and a median of $879.5 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- On a YoY basis, Net Income towards Common Stockholders climbed as much as 305.23% in 2025 and fell as far as 13.44% in 2025.
- A 4-year view of Net Income towards Common Stockholders shows it stood at $1.0 million in 2022, then surged by 92700.0% to $928.0 million in 2024, then soared by 34.7% to $1.2 billion in 2025, then surged by 48.4% to $1.9 billion in 2026.
- Business Quant data shows MCK's Net Income towards Common Stockholders at $1.9 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 1.86 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.63 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 380.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -541.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -9.08 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -2.32 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -2.81 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.86 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 831.00 Mn |
| Mar 31, 2025 | 1.31 Bn |
| Dec 31, 2024 | 928.00 Mn |
| Sep 30, 2024 | 287.00 Mn |
| Jun 30, 2024 | 960.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | -6.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | -2.00 Mn |
| Jun 30, 2021 | -3.00 Mn |
| Jun 30, 2020 | -1.00 Mn |
| Mar 31, 2020 | 6.00 Mn |
| Dec 31, 2019 | -5.00 Mn |
| Sep 30, 2019 | -1.00 Mn |
| Jun 30, 2019 | -6.00 Mn |
| Dec 31, 2018 | -1.00 Mn |
| Sep 30, 2018 | 1.00 Mn |